NHP Stroke Study Publication

Announcing publication of Astrocyte Pharmaceuticals' efficacy evaluation of AST-004 in a NHP model of stroke in the American Heart Association's journal Stroke: "Adenosine A1R/A3R (Adenosine A1 and A3 Receptor) Agonist AST-004 Reduces Brain Infarction in a Nonhuman Primate Model of Stroke."